Filing Details
- Accession Number:
- 0000769993-19-000532
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2019-10-23 17:02:33
- Reporting Period:
- 2019-09-20
- Accepted Time:
- 2019-10-23 17:02:33
- Original Submission Date:
- 2019-09-30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 879682 | Viveve Medical Inc. | VIVE | () | NY |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 769993 | Goldman Sachs & Co. Llc | 200 West Street New York NY 10282 | No | No | No | No | |
| 886982 | Goldman Sachs Group Inc | 200 West Street New York NY 10282 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Units | Disposition | 2019-09-20 | 1,658 | $6.90 | 51,384 | No | 4 | S | Indirect | See Footnotes |
| Common Units | Acquisiton | 2019-09-23 | 39,600 | $5.84 | 90,984 | No | 4 | P | Indirect | See Footnotes |
| Common Units | Disposition | 2019-09-23 | 800 | $6.05 | 90,184 | No | 4 | S | Indirect | See Footnotes |
| Common Units | Acquisiton | 2019-09-24 | 26,200 | $5.64 | 116,384 | No | 4 | P | Indirect | See Footnotes |
| Common Units | Disposition | 2019-09-24 | 800 | $5.57 | 115,584 | No | 4 | S | Indirect | See Footnotes |
| Common Units | Disposition | 2019-09-25 | 10,799 | $5.62 | 104,785 | No | 4 | S | Indirect | See Footnotes |
| Common Units | Disposition | 2019-09-26 | 7,001 | $5.25 | 97,784 | No | 4 | S | Indirect | See Footnotes |
| Common Units | Disposition | 2019-09-27 | 5,359 | $5.10 | 92,425 | No | 4 | S | Indirect | See Footnotes |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | See Footnotes |
| No | 4 | P | Indirect | See Footnotes |
| No | 4 | S | Indirect | See Footnotes |
| No | 4 | P | Indirect | See Footnotes |
| No | 4 | S | Indirect | See Footnotes |
| No | 4 | S | Indirect | See Footnotes |
| No | 4 | S | Indirect | See Footnotes |
| No | 4 | S | Indirect | See Footnotes |
Footnotes
- This statement is being filed by The Goldman Sachs Group, Inc. ("GS Group") and Goldman Sachs & Co. LLC ("Goldman Sachs" and together with GS Group, the "Reporting Persons"). Goldman Sachs is a subsidiary of GS Group. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein.
- The Common Units of the Issuer reported herein as indirectly purchased were beneficially owned directly by Goldman Sachs and indirectly by GS Group.
- Reflects a weighted average sale price of $6.90 per Common Unit, at prices ranging from $6.74 to $7.10 per Common Unit.
- Reflects a weighted average sale price of $6.05 per Common Unit, at prices ranging from $5.82 to $6.28 per Common Unit.
- Reflects a weighted average sale price of $5.64 per Common Unit, at prices ranging from $5.39 to $5.65 per Common Unit.
- Reflects a weighted average sale price of $5.57 per Common Unit, at prices ranging from $5.51 to $5.62 per Common Unit.
- Reflects a weighted average sale price of $5.62 per Common Unit, at prices ranging from $5.45 to $6.05 per Common Unit.
- Reflects a weighted average sale price of $5.25 per Common Unit, at prices ranging from $5.10 to $5.45 per Common Unit.
- Reflects a weighted average sale price of $5.10 per Common Unit, at prices ranging from $4.74 to $5.32 per Common Unit.
Billionaire Hedge Funds
